Anika Therapeutics, Inc. (ANIK) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1249497,
    "name": "Anika Therapeutics, Inc.",
    "stock_name": "Anika Therapeutics, Inc.",
    "full_name": "Anika Therapeutics, Inc.",
    "name_url": "stocks-analysis/anika-therapeutics-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "9.49",
    "chg": 0.06,
    "chgp": "0.64%",
    "dir": 1,
    "prev_price": "9.43",
    "mcapval": "128.90",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2325,
    "indexname": "S&P 500",
    "isin": "US0352551081",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "429.21 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/anika-therapeutics-inc-1249497-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Anika Therapeutics, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-anika-therapeutics-inc-technically-bullish-or-bearish-3545468",
        "imagepath": "",
        "date": "2025-09-20 19:12:25",
        "description": "As of 15 August 2025, the technical trend for Anika Therapeutics, Inc. has changed from bearish to mildly bearish. The weekly MACD is mildly bullish, while the monthly MACD remains bearish, indicating mixed signals. The RSI shows no signal on the weekly chart but is bullish on the monthly chart. Bollinger Bands and moving averages are bearish on the daily timeframe, contributing to the overall mildly bearish stance. \n\nIn terms of performance, the stock has underperformed significantly compared to the S&P 500, with a year-to-date return of -45.69% versus the S&P 500's 12.22%, and a one-year return of -64.90% compared to the S&P 500's 17.14%...."
      },
      {
        "title": "Is Anika Therapeutics, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-anika-therapeutics-inc-overvalued-or-undervalued-3542177",
        "imagepath": "",
        "date": "2025-09-20 17:46:37",
        "description": "As of 5 May 2022, the valuation grade for Anika Therapeutics, Inc. has moved from attractive to risky, indicating a significant deterioration in its valuation outlook. The company appears to be overvalued given its current financial metrics, with a Price to Book Value of 1.10 and an EV to Sales ratio of 0.81, which are concerning in the context of its negative earnings and returns. Additionally, the EV to EBIT and EV to EBITDA ratios are both negative at -3.74 and -4.95, respectively, highlighting the company's struggles in generating profit.\n\nIn comparison to its peers, Anika Therapeutics has a less favorable valuation profile, with CareDx, Inc. rated very attractive with a P/E ratio of -27.91, while AngioDynamics, Inc. is also classified as risky with a P/E of -24.69. The company's recent stock performance has been poor, with a year-to-date return of -45.69%, significantly underperforming the S&P 500's po..."
      }
    ],
    "total": 7,
    "sid": "1249497",
    "stock_news_url": "https://www.marketsmojo.com/news/anika-therapeutics-inc-1249497"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Anika Therapeutics, Inc. technically bullish or bearish?

2025-09-20 19:12:25

As of 15 August 2025, the technical trend for Anika Therapeutics, Inc. has changed from bearish to mildly bearish. The weekly MACD is mildly bullish, while the monthly MACD remains bearish, indicating mixed signals. The RSI shows no signal on the weekly chart but is bullish on the monthly chart. Bollinger Bands and moving averages are bearish on the daily timeframe, contributing to the overall mildly bearish stance. In terms of performance, the stock has underperformed significantly compared to the S&P 500, with a year-to-date return of -45.69% versus the S&P 500's 12.22%, and a one-year return of -64.90% compared to the S&P 500's 17.14%....

Is Anika Therapeutics, Inc. overvalued or undervalued?

2025-09-20 17:46:37

As of 5 May 2022, the valuation grade for Anika Therapeutics, Inc. has moved from attractive to risky, indicating a significant deterioration in its valuation outlook. The company appears to be overvalued given its current financial metrics, with a Price to Book Value of 1.10 and an EV to Sales ratio of 0.81, which are concerning in the context of its negative earnings and returns. Additionally, the EV to EBIT and EV to EBITDA ratios are both negative at -3.74 and -4.95, respectively, highlighting the company's struggles in generating profit. In comparison to its peers, Anika Therapeutics has a less favorable valuation profile, with CareDx, Inc. rated very attractive with a P/E ratio of -27.91, while AngioDynamics, Inc. is also classified as risky with a P/E of -24.69. The company's recent stock performance has been poor, with a year-to-date return of -45.69%, significantly underperforming the S&P 500's po...

View All News